POGO

icon-facebook

Satellite Manual

5.4 Symptom Management

5.5 End of Life

The end of life period is usually considered to be the final days and weeks of life.  This stage is usually recognized when the child’s condition continues to deteriorate despite maximum appropriate treatment, with little chance of improvement.

Revisiting Goals of Care
Goals of care should be established to guide the aims and focus of treatments corresponding to what is most important to the child and family.  As end of life approaches, goals of care may shift from dual goals of cure and comfort to comfort directed care alone. As long as the child’s quality of life is considered to be good, prolonging life and maximizing comfort are often concurrent goals.  The following suggestions may be discussed to create an approach which will most likely achieve the child and family’s goals. 

  1. Location of care (home, hospice, hospital) will be determined by child and family choice, and may change over time. If hospital care is preferred, individual room (if not already in place) allows the family more private time together. Decision about care at home includes interventions still desired as well as nursing and medical support available.  Care in hospice may be preferred by some families to provide access to increased medical supports in a home-like setting. (Link to Settings of Care section)
  2. Review of interventions with discontinuation of those which are no longer desired. Interventions that may be discontinued include blood work, antibiotics, IV fluids and medications, oxygen (unless indicated for comfort), transfusions.  Discussion about natural reductions in appetite and thirst at end of life is essential. The suggestion of offering the child food and drink but allowing the body to determine the need is often helpful to families. 
  3. Allow a natural death – confirm that cardiopulmonary resuscitation is no longer in child’s best interest, benefit and harms of oxygen and suctioning, complete care directive if indicated and provide DNR-C form (Do Not Resuscitate – Confirmation).

 DNR-C form is used by Health Care Facility Staff and Regulated Health Care Providers.  It is a Provincial form used in situations where a plan of treatment has been developed where CPR is no longer medically indicated.  Without this form, Emergency Medical Service Providers are required to perform CPR.  When the family provides this form it allows the responders to provide comfort based support including oxygen and suction.

To order through Ontario Government Central Forms Repository, submit completed order request form (form # 014-0350-93) to OSSDistribution@ontario.ca (preferred option) or fax to 416-679-8192.

Physical changes which may be seen as end of life approaches include the following:
Changes in gastrointestinal functioning with failure to absorb drugs, food and fluid; diarrhea or constipation.  Discussion of these changes may improve understanding of decreased appetite and thirst outlined above.       

  1. Renal dysfunction with oliguria or anuria. Children who are receiving intravenous fluids may become incontinent as end of life approaches, and may have evidence of peripheral and pulmonary edema.  If these occur, discontinuation of IV fluids may be helpful.
  2. Neurological changes with reduced level of consciousness or seizures. This may initially be seen as a gradual decrease in the child’s interest as they focus their energy on things that are most important to them. 
  3. Abnormalities of central control evident close to end of life:
  4. Altered patterns of breathing (Cheyne-Stokes, Kussmaul patterns),
  5. Altered heart rate (often tachycardia, followed by progressive bradycardia),
  6. Temperature (hyper- and hypo-pyrexia).
  7. Changes in skin colour with cyanosis that fluctuates, mottling and peripheral shut down.

 Care interventions which may improve comfort as death approaches:

  1. Review of medication, with discontinuation of all non-essential medication. Oral medications should be converted to subcutaneous or rectal routes (or IV if central line is present). 
  2. Medications made available for symptoms which may occur and instructions on when these medications should be used. Symptoms may include pain, agitation, respiratory tract secretions, nausea and vomiting.
  3. Positioning
    1. Child to identify most comfortable position if able to do so, otherwise care givers should use their best judgment based on the child’s appearance
    2. Consider pressure relieving mattress to avoid or alleviate pressure wounds
  4. Eyes may become dry if there is protrusion of the eye or if they eyelids don’t close fully. Lubricating eye drops may increase comfort.
  5. When fluid intake is minimal, attention to mouth care is essential. Lubricants can be provided or frequent moistening with water (still or carbonated soda water) is comforting.

Other Considerations:

  1. Support is essential throughout the trajectory of disease but especially during the days and weeks leading to death. Maintaining connections with the Oncologist, Case Manager RN, clinic staff, Interlink RN, Social Workers and Spiritual Support caregivers can allow the family trusted people to provide emotional support and coping skills. If not already in place, referral to home palliative care is advised.
  2. Memory making including photographs, hand/foot prints, plaster castings, memory box, scrap book etc.
  3. Religious/spiritual needs discussed and plans put in place.
  4. Funeral planning may be done in advance or may be done after death is confirmed. Identify who will assist family in this planning. 
  5. If death is to occur at home identify who to call (MD support, nursing support, spiritual support) including who is able to confirm death and who should be notified after death.
  6. Autopsy – if medical need, family need, legal requirement
  7. Organ donation – children who die in an Ontario hospital need to be registered with the Trillium Gift of Life Network unless the institution has an exception policy in place. If children or families are interested in tissue donation, TGLN can be contacted in advance or after death to confirm donor eligibility. 
  8. Bereavement resources available in the community for parents, siblings and extended family members should be provided.

Primary authors Ms. Sherley Telisma, Children’s Hospital of Eastern Ontario, Ottawa, and Dr. Christina Vandeboncoeur, Children’s Hospital of Eastern Ontario, Ottawa.  Reviewed by the POGO Satellite Manual Palliative Care Working Group, 2016.

5.6 When a Child Dies in the Satellite Centre
Back to Top

In this Section

  • 1.1 History & Overview
  • 1.2 Acknowledgements
  • 1.3 Committees and Working Groups
  • 1.4 Satellite Manual Disclaimer
  • 2.1 Principles of Satellite Care
  • 2.2 Eligible Patients
    • 2.2.1 Children Eligible for Chemotherapy Administration in a Satellite Centre
    • 2.2.2 Children Not Eligible for Chemotherapy Administration in a Satellite Centre
    • 2.2.3 Children Eligible for the Management of Complications on a Satellite Centre
    • 2.2.4 Eligibility of Children Requiring Supportive Care
  • 2.3 Scope of Satellite Practice
    • 2.3.1 Implementation of Psychosocial Treatment Plan (Process for Communication)
    • 2.3.2 Limitations on Satellite Practice
  • 2.4 Advanced Satellite Practice
  • 3.1 Safe Handling, Administration and Disposal of Chemotherapy Agents
  • 3.2 Accidental Exposure/Spills
  • 3.3 Extravasation Management
    • 3.3.1 Sample Extravasation Documenting Tool
  • 3.4 Injecting SC Medication Via an Insuflon
  • 3.5 Chemotherapy Administration Reference List
  • 3.6 Central Venous Catheter Care
  • 3.7 Chemotherapy Quick Reference
    • 3.7.1 Rapid Hydration Document
    • 3.7.2 Provider Guide: Prevention and Management or Irinotecan induced Diarrhea
    • 3.7.3 Parent Handout: Prevention and Management of Irinotean induced diarrhea
    • 3.7.4 Capizzi Methotrexate
    • 3.7.5 Erwinia L-Asparaginase
  • 4.1 Management of Fever and Neutropenia
    • 4.1.1 Routine Order Sample Sheet
    • 4.1.2 Fever Cards (Sample)
    • 4.1.3 Criteria for low-risk designation. Risk categorization refers to risk of bacteremia and serious complications, including mortality.
  • 4.2 Pentamidine Administration
    • 4.2.1 Inhaled Pentamidine
    • 4.2.2 Intravenous Pentamidine
  • 4.3 Antiemetics
  • 4.4 Treatment of Varicella-Zoster Infections
  • 4.5 TPN Document
  • 4.6 Immunization of Children with Cancer
  • 4.7 Transfusion
  • 4.8 When to consult the Tertiary Centre
  • 5.1 Palliative Care Overview
  • 5.2 Communication
  • 5.3 Settings of Care
  • 5.4 Symptom Management
  • 5.5 End of Life
  • 5.6 When a Child Dies in the Satellite Centre
    • 5.6.1 Reconciling your grief
    • 5.6.2 Funeral arrangement checklist
    • 5.6.3 Helping Children who grieve
    • 5.6.4 Coping with the Holidays
    • 5.6.5 The grieve experience
  • 6.1 Goals and Objectives
  • 6.2 Participant Site Selection
    • 6.2.1 Tertiary Site Selection
    • 6.2.2 Community Site Selection
  • 6.3 POGO’s Roles
    • 6.3.1 PHIPA, Privacy and Research
  • 6.4 Funding
    • 6.4.1 Funding Support for Tertiary Activity
    • 6.4.2 Financial Support for Pediatric Oncology Community Activity
  • 6.5 Infrastructure and Formal Requirements
    • 6.5.1 Tertiary Partners’ Role in Provincial Pediatric Oncology Satellite Program
    • 6.5.2 Satellite Partners’ Role in Provincial Pediatric Oncology Satellite Program
  • 7.1 Preamble
  • 7.2 Investigator responsibilities
  • 7.3 Training Requirements
    • 7.3.1 General Training for Conduct of Research
    • 7.3.2 Protocol Specific Training
  • 7.4 Research Activites that may be completed in satellite centres under supervision of DSI
  • 7.5 Research Activities to be completed in Tertiary Centres Only
  • 7.6 Recognition and Reporting of Adverse Events (AEs)
  • 7.7 Data Transfer
  • 7.8 Pharmacy Drug Accountibility
  • 7.9 Site Inspections and Quality Assurance
  • 8.1 Pediatric Oncology Shared Care Initial Data Transfer Sheet
  • 8.2 Shuttle Sheet
  • 8.3 Psychosocial Communication Tool
  • 9.1 Satellite Readiness/ Preparedness Checklist
  • 9.2 Education Report for Tertiary Centres
  • 9.3 Education Report for Satellite Centres
  • 9.4 Vital Signs Report
  • 9.5 Self- Assessment
  • 9.6 Satellite Contact Form
  • 9.7 Annual Satellite Caseload Report
  • 9.8 POGO Provincial Satellite Program Annual Accounting Report
Back to table of contents
Search our Manual
Have a question?
Contact us at: satellite@pogo.ca
  • About Us
    • Diversity, Equity, Inclusion
    • Childhood Cancer Care Plan
    • Our Mission and Vision
    • Our Board
    • Our Partners
    • Our Donors
    • Privacy
    • History & Milestones
    • Reports
    • Newsroom
    • Job Opportunities
    • Accessibility
    • Staff List
  • Programs & Support
    • Patient Care Programs
    • Financial Assistance
    • Survivor Care
    • Cancer Resources
    • Childhood Cancer Resource Guide
    • Inspiring Stories
    • Clinical and Program Advisory Committees
  • Education
    • POGO AfterCare Education Day
    • POGO Multi-Disciplinary Symposium on Childhood Cancer
    • All Education Events & Conferences
  • Healthcare Practice
    • COVID-19 Updates
    • Pediatric Oncology Nursing
    • Clinical Practice Guidelines
    • Satellite Manual
  • Research & Data
    • 2020 POGO Surveillance Report
    • POGO Research Unit
    • POGONIS – Childhood Cancer Database
    • Data Reports
    • Data Requests
  • Get Involved
    • Pajamas and Pancakes
    • Birthday Parties for POGO
    • Events
    • Volunteer
  • Ways to Give
    • Donate
    • Gifts of Stock and Securities
    • Become a Corporate Partner
    • Gifts in Honour/Memory
    • Legacy Gifts
    • Shop Online/Earn Cash Back

©2020 Pediatric Oncology Group of Ontario

480 University Avenue, Suite 1014 | Toronto, Ontario, M5G 1V2, Canada | Charitable Registration Number: 871067245RR0001 | Contact Us
1-855-FOR POGO (367-7646) | Website Privacy Policy | Website Disclaimer | Satellite Manual Disclaimer |